 NEW YORK, Aug. 11, 2021 GLOBE NEWSWIRE -- Royalty Pharma plc Nasdaq: RPRX today reported financial results for the second quarter of 2021 and raised full-year 2021 guidance for Adjusted Cash Receipts 1 a non-GAAP financial measure. 